Skip to main content
American Journal of Epidemiology logoLink to American Journal of Epidemiology
. 2012 Apr 16;175(11):1191–1199. doi: 10.1093/aje/kwr393

Child Intellectual Development in Relation to Cytokine Levels in Umbilical Cord Blood

Ondine S von Ehrenstein *, Gila I Neta, William Andrews, Robert Goldenberg, Alice Goepfert, Jun Zhang
PMCID: PMC3370884  PMID: 22508393

Abstract

Although cytokines play a dual role in the developing neurologic system and in prenatal immune reactions, relations between fetal cytokine levels and child intellectual development remain unknown. The authors investigated associations between umbilical cord serum cytokine concentrations and intellectual outcomes in 369 children within a prospective cohort study, the Eunice Kennedy Shriver National Institute of Child Health and Human Development-University of Alabama Infant Growth Study (1985–1988). Concentrations of interferon-γ (IFN-γ), tumor necrosis factor-α (TNF-α), and interleukins 4, 10, and 12p70 were determined. The Wechsler Preschool and Primary Scale of Intelligence–Revised was administered at age 5 years, producing verbal and performance intelligence quotients (VIQ and PIQ); associations with each cytokine were evaluated using linear and logistic regression. Log-unit increases in IFN-γ (adjusted odds ratio (aOR) = 0.67, 95% confidence interval (CI): 0.46, 0.98) and interleukin-12p70 (aOR = 0.43, 95% CI: 0.21, 0.87) were inversely associated with low PIQ (score <70). One log-unit increase in TNF-α was associated with a reduced odds ratio for low VIQ (score <70) among preterm children (aOR = 0.11, 95% CI: 0.01, 0.94) and an elevated odds ratio for low VIQ among small-for-gestational-age children (aOR = 3.96, 95% CI: 0.99, 15.9). IFN-γ, which is involved in neurogenesis and perinatal adaptive immunity, may be related to fetal neurologic development overall, while TNF-α may be a marker of intellectual development in vulnerable subgroups.

Keywords: child development, cohort studies, cytokines, intelligence tests, interferon-gamma, tumor necrosis factor-alpha, umbilical cord


Severe infant neurologic illness, such as white matter lesions and cerebral palsy (1), and later-life psychiatric illnesses like schizophrenia (2, 3) have been shown to be related to prenatal infection, especially among early preterm births (47). Few studies have involved measurement of cytokines, and the authors of these studies have suggested that proinflammatory cytokines, like interleukin (IL)-6 (8), may be mediators for the observed associations (7, 911). Because cytokines play a dual role in brain function (12) and in-utero immune responses (9, 13), they are thought to mediate the complex interplay between normal and pathologic prenatal immune processes and critical processes of fetal neurodevelopment (1420), thereby possibly influencing long-term nervous system function.

Experimental studies have shown that a number of cytokines are involved in neurogenesis, synaptic maturation, and the generation of neuronal networks and other important processes of brain development (12) and that peripheral cytokines may directly or indirectly affect cognition (9, 12). Both overexpression and deficiency of certain cytokines can positively and negatively influence hippocampus-related memory and synaptic plasticity under pathologic and physiologic conditions, particularly in aging processes (21).

Certain cytokines such as tumor necrosis factor-α (TNF-α) are common immune and neuronal cell signaling proteins (16) and have been shown to pass through the blood-brain barrier via active transport mechanisms or indirectly (22, 23); thus, they may mediate bidirectional brain-immune communication across the blood-brain barrier during fetal development (18, 24). The TNF-α signal has been shown to exert protective effects in mice experiments (25) and may play a role in learning and memory by promoting synaptic plasticity (26), suggesting, in turn, that disruption of these processes may lead to cognitive impairment. In animal models, interferon-γ (IFN-γ) has been shown to enhance neurogenesis and to improve spatial learning and memory—processes critical for intellectual development in early life (27). Thus, scenarios involving cytokines during the prenatal period may influence later intellectual abilities (9, 1214, 20).

While insights into the interface of in utero cytokine function and central nervous system processes have steadily increased, mostly on the basis of animal models (15), human longitudinal data for elucidating whether in utero cytokine concentrations at birth are related to intellectual development in children are scarce to date. A body of research has evolved around the role of prenatal cytokines as markers of risk for preterm birth (28) and small-for-gestational-age (SGA) birth (29, 30). Neta et al. (29) previously reported that an increase in TNF-α concentration was associated with a 2-fold increase in the risk of preterm birth and that IFN-γ was inversely associated with the risk of SGA birth, especially among preterm births.

We thus hypothesized that umbilical cord blood concentrations of circulating inflammatory cytokines may be related to child intellectual development and that preterm birth and SGA status, respectively, may moderate the relation between levels of certain cytokines at birth and intellectual function in children. We investigated associations between cytokines in umbilical cord serum and measures of intellectual function assessed prospectively among children followed from early pregnancy to the age of 5 years.

MATERIALS AND METHODS

Study design and population

This investigation was nested within the Infant Growth Project, a longitudinal study conducted by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the University of Alabama at Birmingham that was originally designed to determine associations between being born SGA at term and child cognitive function (3133). The study population has been described previously (3133). Briefly, investigators screened 3,721 women from a low-income, primarily African-American population who were receiving prenatal care from an Alabama county health department between 1985 and 1988. Of 2,661 eligible women with parity 1 and 2 who sought care at less than 17 weeks of gestation, 1,545 gave written informed consent and were enrolled in the original SGA study (31). Of this original cohort, 27 women had twin pregnancies that were excluded and 27 were lost to follow-up; among the remaining singleton births, 893 umbilical cord blood samples were taken. Of the pregnancy cohort, 983 pregnancies were eligible for follow-up (33) and 692 (70.4%) children were tested at the age of 5 years (32); 369 also had cord blood samples available that were assayed for cytokines. The 369 subjects who were included in the current study and those who had been included in the original pregnancy cohort were similar with regard to demographic variables, birth weight, and other predefined risk factors for SGA (see Web Table 1, which is posted on the Journal’s Web site (http://aje.oxfordjournals.org/)) (29). The study was reviewed and approved by the institutional review boards of the National Institute of Child Health and Human Development and the University of Alabama at Birmingham.

Pregnancy and birth outcomes

During each of 3 prenatal clinic visits, information on maternal medical history and demographic, socioeconomic, and anthropometric characteristics was collected by questionnaire. Gestational age was estimated on the basis of the last menstrual period and was confirmed by ultrasound scanning (usually before 21 weeks). The ultrasound information was used if the estimates differed by 2 weeks or more from the last menstrual period. Preterm birth was defined as birth at less than 37 weeks of gestation. Infants were classified as SGA if they were below the 10th percentile of weight-for-age based on a fetal growth standard (34). Additional information collected at the time of delivery included maternal diagnoses that might be associated with inflammation or infection (i.e., diagnosis of preeclampsia, chorioamnionitis, intrapartum fever, or hypertension) and whether the mother was taking antibiotics during labor. Women who reported smoking at least 1 cigarette per day on average at any of the prenatal clinic visits were classified as smokers. Alcohol consumption during pregnancy was measured as a dichotomous variable (yes/no). Information on maternal height and prepregnancy weight, education, and household income was ascertained with a self-administered questionnaire at the first prenatal visit (31).

Assessment of intellectual function

Intellectual function was assessed at the age of 5 years with the Wechsler Preschool and Primary Scale of Intelligence–Revised, producing verbal and performance intelligence quotients (VIQ and PIQ, respectively) calculated on the basis of sets of subtests assessing verbal and nonverbal abilities (35). Testing was performed at the University of Alabama at Birmingham by 2 evaluators who were extensively trained in the assessment methods and had no knowledge of SGA birth status or any other factors assessed in the study; testing procedures and the results were reviewed regularly by 2 clinical psychologists. In this investigation, limitations in intellectual function were defined as scores less than 70 in VIQ or PIQ, based on the American Association on Intellectual and Developmental Disabilities’ current definition of “intellectual disability” (36). Maternal receptive language was measured using the Peabody Picture Vocabulary Test–Revised (37), and the quality of the child’s home environment was assessed with the Home Screening Questionnaire (38).

Measurement of cytokine concentrations

Cord blood samples were collected at birth. From each participant, an aliquot was transported on dry ice to the laboratory of the National Institute of Child Health and Human Development (Bethesda, Maryland), where samples were continuously stored at −80°C until the time of cytokine analysis. All samples were analyzed for cytokine levels simultaneously in 2001. Concentrations of IL-1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12p70, TNF-α, IFN-γ, and granulocyte-macrophage colony-stimulating factor were measured simultaneously using the Linco Immunoassay and Luminex 100 IS (Millipore Corporation (Billerica, Massachusetts) and Luminex (Austin, Texas)) based on bead mapping technology using color-coded microscopic beads coated with a specific immunoassay reagent, as reported elsewhere (29). The reagents on the surfaces of the beads recognize and capture specific cytokines through a biochemical binding reaction. Immunoassay results were detected using a Luminex 100 flow cytometer (Millipore Corporation and Luminex). Laboratory technicians were blinded to the outcome status of subjects. The reference curve concentration range lies between 3.2 pg/mL (the lower limit of detection) and 10,000 pg/mL (the upper limit of detection). Cytokines with more than 60% of the samples with levels greater than the lower limit of detection included 3 proinflammatory cytokines (TNF-α, IFN-γ, and IL-12p70) and 2 antiinflammatory cytokines (IL-4 and IL-10), which were further evaluated. The remaining cytokines had fewer than 50% of samples above the lower limit of detection and were not considered (39). Studies suggest that cytokine levels are stable over time when stored at −80°C (40, 41). To ensure that there was no substantial cytokine degradation in the stored samples, we compared the cytokine concentrations from the Alabama Infant Growth Project cohort with those of a similar cohort in Baltimore, Maryland, for which the samples had been stored for only 1 year; the ranges of values were similar (29).

Statistical analysis

Because cytokine concentrations were right-skewed, they were analyzed on a logarithmic scale. Cytokine concentrations below the limit of detection were imputed using the limit of detection divided by the square root of 2 (42). Details of the distribution and concentrations of cytokines have been reported previously for the sample of 370 subjects (29). For this study (n = 369), the percentages of samples below the limit of detection were 3% for TNF-α, 20% for IFN-γ, 34% for IL-12p70, 39% for IL-10, and 37% for IL-4, with geometric mean concentrations (pg/mL) of 8.76 for TNF-α, 5.92 for IFN-γ, 3.97 for IL-12p70, 4.40 for IL-10, and 8.24 for IL-4.

All potentially relevant variables were selected a priori and evaluated for associations with cytokines and the intellectual function measures, respectively, including: maternal age, race/ethnicity (African-American/black vs. non-Hispanic white), maternal education (less than high school, high school, or high school plus 1 year of college), maternal Peabody Picture Vocabulary Test–Revised score, poverty (income <$9,600/year) (43), Home Screening Questionnaire score, smoking/alcohol drinking during pregnancy, child gender, type of labor (e.g., induced), cesarean delivery (yes/no), birth weight, preterm birth (<37 weeks), SGA birth (34), use of antibiotics during labor, intrapartum fever (>100.4°F), chorioamnionitis, hypertension, and preeclampsia. In the final adjusted models, we retained those variables as covariates that were associated with at least one of the cytokines and the intelligence quotient (IQ) measures. Geometric mean values for the cytokine concentrations were calculated according to VIQ (<70 vs. ≥70) and PIQ (<70 vs. ≥70) (36), and the differences were assessed using t tests. To assess the associations between each log-cytokine value and VIQ and PIQ, respectively, separate unadjusted and adjusted linear and logistic (for categorical outcomes) regression models were fitted. To investigate whether preterm birth (<37 weeks vs. ≥37 weeks) or SGA status modified relations between the cytokines and intellectual function, we conducted analyses stratified by preterm birth status (preterm vs. term) and SGA birth status (SGA vs. non-SGA). Stata 11.0 was used for all statistical analyses (StataCorp LP, College Station, Texas).

RESULTS

Basic characteristics of the study population are shown in Table 1. Average birth weight and gestational age were in the normal range; the percentage of African Americans was 72%. None of the variables indicating maternal inflammation—that is, preeclampsia (n = 8), chorioamnionitis (n = 4), intrapartum fever (n = 6), hypertension (n = 22), use of antibiotics during labor (n = 22), self-reported maternal infections (n = 61), or cesarean delivery (n = 52)—were related to VIQ or PIQ.

Table 1.

Basic Characteristics of the Study Population (n = 369), Infant Growth Project, Jefferson County, Alabama, 1985–1988

No. of Subjects Total %a Mean (SD)
Infant characteristics
    Female gender 179 369 48.5
    Gestational age, weeks 38.2 (2.7)
    Birth weight, g 3,031 (649)
    Preterm birth (<37 weeks) 72 369 19.5
    Small-for-gestational-ageb birth 75 369 20.3
Race/ethnicity
    White 104 369 28.2
    Black/African-American 265 369 71.8
Maternal characteristics
    Age, years 24.2 (4.3)
    Maternal education
        Less than high school diploma 123 368 33.4
        High school diploma 126 368 34.2
        ≥1 years of college 119 368 32.3
    PPVT-R score 73 (12.9)
Pregnancy characteristics
    Cesarean delivery 52 329 15.8
    Infection during pregnancy 61 335 18.2
    Antibiotics during labor 22 337 6.5
    Intrapartum fever >100.4°F 6 321 1.9
    Smoking during pregnancy 158 363 43.5
    Alcohol drinking during pregnancy 118 369 32.0
Povertyc 226 322 70.2
Home Screening Questionnaire score 36.8 (6.2)
Child IQ score <70
    Verbal IQ 47 369 12.7 84.2 (11.6)
    Performance IQ 43 369 11.7 84.5 (13.4)

Abbreviations: IQ, intelligence quotient; PPVT-R, Peabody Picture Vocabulary Test–Revised; SD, standard deviation.

a

Denominators vary because of missing values for different variables; percentages may not total 100 because of rounding.

b

Below the 10th percentile of weight-for-age based on a fetal growth standard (34).

c

Family income below $9,600 per year.

The geometric mean concentrations of the proinflammatory cytokines IFN-γ and IL-12p70 were significantly lower among children with low (<70) PIQ scores than among those with higher PIQ scores (for IFN-γ, 4.7 pg/mL vs. 6.1 pg/mL (P < 0.05); for IL-12p70, 3.4 pg/mL vs. 4.0 pg/mL (P < 0.05)) (Table 2).

Table 2.

Geometric Mean Levels of Umbilical Cord Serum Cytokines According to Verbal and Performance Intelligence Quotient Scores (n = 369), Infant Growth Project, Jefferson County, Alabama, 1985–1988

Cytokine VIQ Score PIQ Score
<70 (n = 47) ≥70 (n = 322) <70 (n = 43) ≥70 (n = 326)
GM, pg/mL SD GM, pg/mL SD GM, pg/mL SD GM, pg/mL SD
Interferon-γ 6.3 2.3 5.9 2.6 4.7* 2.1 6.1 2.6
Tumor necrosis factor-α 8.8 1.6 8.7 1.6 8.6 1.9 8.7 1.6
Interleukin-12p70 3.8 1.5 4.0 1.7 3.4* 1.5 4.0 1.7
Interleukin-10 4.3 2.3 4.4 2.1 4.4 2.4 4.4 2.1
Interleukin-4 8.1 2.0 8.3 2.7 6.7 2.4 8.5 2.6

Abbreviations: GM, geometric mean; PIQ, performance intelligence quotient; SD, standard deviation; VIQ, verbal intelligence quotient.

* P < 0.05 (2-sided t test).

Associations between cytokine concentrations and limitations in intellectual function, that is, scoring less than 70 (reference category: ≥70) (36), were investigated in unadjusted and adjusted logistic regression models; the latter included birth weight, gender, race/ethnicity, and smoking (VIQ only). An increase of 1 log-unit in the proinflammatory cytokines IFN-γ and IL-12p70 was associated with approximately 30%–50% reduced odds of scoring less than 70 for PIQ (Table 3). For IL-4, the effect estimate was similar in magnitude to that for IFN-γ, but the 95% confidence interval was wider (P = 0.07). There was no association between the 5 cytokines and a VIQ test score less than 70 among all subjects. Using the intellectual outcomes measured as continuous variables in adjusted linear regression models, no significant (P < 0.05) associations with the log cytokines were found; the estimate for IL-4 and PIQ was somewhat increased, but the 95% confidence interval included the null value (P = 0.06) (Table 3).

Table 3.

Adjusted Odds Ratiosa for Low (Score <70) Verbal (VIQ) and Performance (PIQ) Intelligence Quotient Scores (Reference Category: ≥70) and Adjusted Linear Regression Coefficientsa for VIQ and PIQ as Continuous Variables at Age 5 Years in Relation to Umbilical Cord Serum Log Cytokine Concentrations (pg/mL) (n = 369), Infant Growth Project, Jefferson County, Alabama, 1985–1988

Cytokine VIQ Score <70 PIQ Score <70 VIQ (Continuous) PIQ (Continuous)
OR 95% CI OR 95% CI β 95% CI β 95% CI
Interferon-γ 1.03 0.74, 1.44 0.67* 0.46, 0.98 0.43 −0.81, 1.67 0.79 −0.68, 2.26
Tumor necrosis factor-α 0.97 0.50, 1.86 0.81 0.41, 1.60 0.66 −1.76, 3.09 −0.53 −3.41, 2.34
Interleukin-12p70 0.73 0.38, 1.37 0.43* 0.21, 0.87 1.59 −0.70, 3.88 1.93 −0.77, 4.64
Interleukin-10 0.85 0.55, 1.31 0.90 0.59, 1.40 0.87 −0.63, 2.37 0.39 −1.39, 2.18
Interleukin-4 0.95 0.68, 1.32 0.71 0.49, 1.02 0.60 −0.61, 1.82 1.34 −0.08, 2.76

Abbreviations: CI, confidence interval; OR, odds ratio; PIQ, performance intelligence quotient; VIQ, verbal intelligence quotient.

* P < 0.05 (logistic regression; reference category: ≥70).

a

Adjusted for birth weight, gender, and race/ethnicity; VIQ results were additionally adjusted for smoking during pregnancy (any).

To explore potentially modifying effects of preterm or SGA status on associations between cytokine concentrations and limitations in intellectual function, we conducted stratified analyses by preterm birth status (Table 4) and SGA birth status (Table 5). Among children who were born preterm (mean gestational age = 33.9 weeks; standard deviation, 2.3), a 1 log-unit increase in TNF-α was associated with a reduced odds ratio for a VIQ score less than 70 (adjusted odds ratio (OR) = 0.11, 95% confidence interval (CI): 0.01, 0.94), but not among term-born children (adjusted OR = 1.32, 95% CI: 0.65, 2.66) (Table 4). Among SGA-born children, 1 log-unit increase in TNF-α was associated with an elevated odds ratio for VIQ <70 (adjusted OR = 3.96, 95% CI: 0.99, 15.9), while no association with TNF-α was seen among those born non-SGA (Table 5). Estimates for IL-12p70 and PIQ remained significant among term and non-SGA births, while confidence intervals widened for IFN-γ (Tables 4 and 5). We also evaluated all models in Tables 3–5 without adjusting for birth weight, and the findings remained very similar (Web Tables 2–4).

Table 4.

Adjusted Odds Ratiosa for Low (Score <70) Verbal and Performance Intelligence Quotient Scores (Reference Category: ≥70) at Age 5 Years in Relation to Umbilical Cord Serum Log Cytokine Concentrations, by Preterm Birth Status (n = 369), Infant Growth Project, Jefferson County, Alabama, 1985–1988

Cytokine Preterm Birth (n = 72) Term Birth (n = 297)
VIQ Score <70 PIQ Score <70 VIQ Score <70 PIQ Score <70
OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Interferon-γ 1.08 0.51, 2.28 0.66 0.21, 2.12 1.04 0.71, 1.52 0.72 0.47, 1.09
Tumor necrosis factor-α 0.11* 0.01, 0.94 0.05 0.001, 2.43 1.32 0.65, 2.66 1.09 0.55, 2.18
Interleukin-12p70 0.49 0.12, 2.04 0.84 0.10, 7.43 0.82 0.40, 1.66 0.43* 0.20, 0.94
Interleukin-10 0.53 0.18, 1.59 1.45 0.38, 5.54 0.94 0.60, 1.49 0.92 0.59, 1.44
Interleukin-4 0.91 0.40, 2.09 0.90 0.24, 3.27 0.96 0.67, 1.37 0.72 0.49, 1.06

Abbreviations: CI, confidence interval; OR, odds ratio; PIQ, performance intelligence quotient; VIQ, verbal intelligence quotient.

* P < 0.05 (logistic regression; reference category: ≥70).

a

Adjusted for birth weight, gender, and race/ethnicity; VIQ results were additionally adjusted for smoking during pregnancy (any).

Table 5.

Adjusted Odds Ratiosa for Low (Score <70) Verbal and Performance Intelligence Quotient Scores (Reference Category: ≥70) at Age 5 Years in Relation to Umbilical Cord Serum Log Cytokine Concentrations, by Small-for-Gestational-Age Status (n = 369), Infant Growth Project, Jefferson County, Alabama, 1985–1988

Cytokine SGA Birth (n = 75) Non-SGA Birth (n = 294)
VIQ Score <70 PIQ Score <70 VIQ Score <70 PIQ Score <70
OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Interferon-γ 0.90 0.46, 1.73 0.65 0.32, 1.31 1.13 0.75, 1.69 0.73 0.46, 1.17
Tumor necrosis factor-α 3.96*b 0.99, 15.9 2.22 0.69, 7.12 0.53 0.23, 1.23 0.52 0.22, 1.23
Interleukin-12p70 1.10 0.36, 3.40 0.78 0.25, 2.41 0.62 0.28, 1.36 0.32* 0.13, 0.82
Interleukin-10 1.23 0.68, 2.22 1.22 0.68, 2.18 0.66 0.35, 1.23 0.75 0.40, 1.42
Interleukin-4 1.00 0.48, 2.07 0.92 0.45, 1.86 0.96 0.65, 1.41 0.67 0.43, 1.05

Abbreviations: CI, confidence interval; OR, odds ratio; PIQ, performance intelligence quotient; VIQ, verbal intelligence quotient.

* P < 0.05 (logistic regression; reference category: ≥70).

a

Adjusted for birth weight, gender, and race/ethnicity; VIQ results were additionally adjusted for smoking during pregnancy (any).

b

Borderline-significant (P = 0.052).

Thirteen of the 72 preterm children were also SGA (18%). After excluding these children from the analysis, the inverse association between TNF-α concentrations and VIQ <70 (Table 4) was strengthened among preterm children (adjusted OR = 0.04, 95% CI: 0.002, 0.69). In addition, an inverse association for VIQ <70 and IL-12p70 concentrations was found (adjusted OR = 0.11, 95% CI: 0.01, 0.96). Among term SGA children, the association between VIQ and TNF-α was slightly weakened (adjusted OR = 3.18, 95% CI: 0.84, 12.1; P = 0.09); for the relation of PIQ to IFN-γ concentrations, the estimate also changed slightly (adjusted OR = 0.45, 95% CI: 0.18, 1.11; P = 0.08), while the remaining findings were virtually unchanged.

DISCUSSION

Our study found that increases in circulating concentrations of the proinflammatory T helper 1 cytokines IFN-γ and IL-12p70 at birth were related to reduced odds of developing a low PIQ at age 5 years of approximately 30% and 50%, respectively. The association between low PIQ and IL-4, a T helper 2 cytokine, was of similar magnitude as that for IFN-γ but with a wider confidence interval. For TNF-α, also a critical T helper 1 cytokine, 1 log-unit increase was protective against a low VIQ among preterm children but was associated with increased odds of low VIQ among SGA children. Our findings among SGA and preterm births support a differential role of TNF-α in the developing neurologic system (44, 45). Overall, our results suggest that certain inflammatory cytokines in umbilical cord blood may be markers of perinatal processes directly or indirectly involved in child intellectual development.

A body of research has suggested that severe infant neurologic illnesses, such as white matter lesions or cerebral palsy (1), are related to clinically severe prenatal infection, with potentially differential effects according to gestational age and weight at birth (47). Investigators have concluded that cytokines might be mediators of underlying processes (47). However, most of those studies did not assess actual cytokine concentrations or IQ. Few studies have measured cytokines at birth and assessed cognitive development in children prospectively. In one earlier study conducted among very preterm infants born at 23–31 weeks of gestation, Andrews et al. (46) found no association between cord blood concentration of IL-6 or any maternal inflammatory marker, including severe chorioamnionitis, and IQ at 6 years of age. No other cytokines were assessed in that study. The findings with regard to maternal inflammatory markers are in line with ours, although we had few women with reported clinical markers of more severe inflammation such as chorioamnionitis (n = 4) in our sample. We cannot directly compare the findings of Andrews et al. (46) with ours, since our study included few very preterm births (<32 weeks: n = 9), and we could not assess IL-6, which is known to be an important regulator of neurogenesis in adults and in some neurodegenerative diseases (47) but has an unclear role in early neurodevelopment.

While there is a paucity of human data, evidence from animal and in vitro studies is starting to accumulate. Studies with mice have shown that IL-12p70, which is secreted from dendritic cells and stimulates IFN-γ production in naive T cells, can induce de novo neurogenesis and remyelation. Moreover, mice treated with IL-12p70 showed significant improvement in locomotor function (48). Experimental research also suggests that IFN-γ plays a protective role by inducing neurogenesis, with positive effects on learning and memory (12, 27, 48). IFN-γ was shown to promote neuronal progenitor cell differentiation in vitro, and it has been suggested that IFN-γ activity can promote the early development of the central nervous system (49). Overall, the experimental evidence supports our findings of a possible protective role of IFN-γ and IL-12p70 during neurologic development, possibly manifested in inductive and deductive reasoning as captured by the PIQ tests and which are processes thought to be largely related to biologic factors.

Another possible explanation can be that higher levels of IFN-γ and IL-12 may be markers of a better developed perinatal immune system, which is indicative of a more “robust” immune system in childhood (better protection against viral and bacterial infections) with better intellectual development. Unfortunately, in this study we did not have information about the number of postnatal infections with which to evaluate this hypothesis.

Elevated TNF-α concentrations were protective against VIQ <70 in preterm children but were associated with increased odds of VIQ <70 among SGA children. No association was observed with VIQ <70 among term or non-SGA-born children or between TNF-α and PIQ <70 in any subgroup. To our knowledge, no other investigation of TNF-α concentrations at birth among preterm or SGA births in relation to intellectual function has been conducted to date. In experimental studies, under immunologically unchallenged conditions, TNF-α has been shown to be essential for normal memory and learning in mice (50). TNF-α has been linked to both neurodevelopment, by promoting the generation of neuronal networks and cell survival (51), and neurodegeneration, by triggering apoptosis (52). In young mice, TNF-α deficiency was detrimental for spatial memory but had opposite effects on older mice (50). TNF-α promoted in a dose- and time-dependent manner cell differentiation of dopaminergic neurons exerting neurotoxic and neuroprotective effects, suggesting a time-dependent switch of the TNF-α response during neurodevelopment (44). In a child brain imaging study, Betjemann et al. (53) demonstrated relations between specific cognitive functions and neuronal structures. Because TNF-α apparently exerts its activity with certain neuronal structures (44), it is possible that it interacts under challenging conditions (i.e., SGA or preterm birth) specifically with structures linked with VIQ. In a twin study, associations were seen between nutritional fetal growth restriction and reductions in VIQ, while no effect on PIQ was seen, indicating that neuronal areas that underlie verbal abilities are more vulnerable to suboptimal in utero growth conditions than those associated with PIQ (54). This is in line with our findings suggesting that elevated TNF-α can be a marker for increased risk of low VIQ among growth-restricted children. One explanation for the different direction of TNF-α effects in preterm birth may be the time-dependent and cell-specific nature of TNF-α-mediated processes; thus, effects involving the same structures may be expressed differently, conditional on gestational age (44, 50, 51).

We observed effects on the binary outcome of intellectual limitations defined a priori based on the guidelines of the American Association on Intellectual and Developmental Disabilities and as done in previous reports (46), rather than on the continuous IQ outcomes. This suggests that a 1 log-unit increase in levels of certain cytokines is associated with the odds of having a low VIQ or PIQ rather than with change in mean IQ measures. This may suggest the existence of a subgroup of children who are particularly susceptible to processes associated with changes in cytokine concentrations.

Our longitudinal study entailed several limitations. We could not measure actual central nervous system concentrations of the cytokines. However, a body of evidence supports the notion that proinflammatory peripheral cytokines pass and exert activity beyond the blood-brain barrier in utero (18, 22, 24, 45, 55, 56). Cytokine patterns have been shown to vary across lengths of gestation (58), as well as potentially by environmental determinants (58). Ideally, we would have had consecutive prenatal and postnatal child and maternal in utero peripheral and central nervous system measurements of cytokines with which to compare the effects of the cytokines at the different time points and in different compartments, as well as objective information on timing and severity of prenatal inflammation. Cotinine levels in umbilical cord blood were not measured, and secondhand exposure to tobacco smoke during pregnancy was not assessed. Our sample size was relatively small. Larger numbers in subgroups would have allowed more detailed analysis of a possible impact of inflammatory and noninflammatory preterm birth, as well as of maternal inflammatory illnesses.

Our study had a number of marked strengths, particularly the prospective nature of the study and the availability of detailed medical information, which allowed us to assess a large number of potentially confounding variables. Confounding is very unlikely to explain the results reported herein, as the final models controlled for all important confounders in this sample. Moreover, we can rule out observer and reporting bias, since the cytokine analysis was conducted blinded to the children’s intellectual outcome status.

In summary, inflammatory cytokines are part of a complex cellular bidirectional communication network with responses related to synergistic or antagonistic actions of its various components. It is possible that the effects we observed are caused indirectly, via immune system response, or directly, by cytokine action at and beyond the fetal blood-brain barrier. The results of this study may help identify at birth predictive markers of potentially susceptible subgroups. Further epidemiologic research closely integrating in utero molecular markers is needed to advance the understanding of complex mechanisms in early human neurologic and cognitive development.

Supplementary Material

Web Tables

Acknowledgments

Author affiliations: Department of Community Health Sciences, School of Public Health, University of California, Los Angeles, Los Angeles, California (Ondine S. von Ehrenstein); Epidemiology Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland (Gila I. Neta); Department of Obstetrics and Gynecology, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama (William Andrews, Alice Goepfert); Department of Obstetrics and Gynecology, College of Medicine, Drexel University, Philadelphia, Pennsylvania (Robert Goldenberg); and MOE-Shanghai Key Laboratory of Children’s Environmental Health, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China (Jun Zhang).

This study was supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health.

The authors thank their collaborators at the University of Alabama at Birmingham.

Conflict of interest: none declared.

Glossary

Abbreviations

CI

confidence interval

IFN-γ

interferon-γ

IL

interleukin

IQ

intelligence quotient

OR

odds ratio

PIQ

performance intelligence quotient

SGA

small for gestational age

TNF-α

tumor necrosis factor-α

VIQ

verbal intelligence quotient

References

  • 1.Yoon BH, Park CW, Chaiworapongsa T. Intrauterine infection and the development of cerebral palsy. BJOG. 2003;110(suppl 20):124–127. doi: 10.1016/s1470-0328(03)00063-6. [DOI] [PubMed] [Google Scholar]
  • 2.Babulas V, Factor-Litvak P, Goetz R, et al. Prenatal exposure to maternal genital and reproductive infections and adult schizophrenia. Am J Psychiatry. 2006;163(5):927–929. doi: 10.1176/ajp.2006.163.5.927. [DOI] [PubMed] [Google Scholar]
  • 3.Pearce BD. Schizophrenia and viral infection during neurodevelopment: a focus on mechanisms. Mol Psychiatry. 2001;6(6):634–646. doi: 10.1038/sj.mp.4000956. [DOI] [PubMed] [Google Scholar]
  • 4.Adams-Chapman I, Stoll BJ. Neonatal infection and long-term neurodevelopmental outcome in the preterm infant. Curr Opin Infect Dis. 2006;19(3):290–297. doi: 10.1097/01.qco.0000224825.57976.87. [DOI] [PubMed] [Google Scholar]
  • 5.Pickler R, Brown L, McGrath J, et al. Integrated review of cytokines in maternal, cord, and newborn blood: part II—associations with early infection and increased risk of neurologic damage in preterm infants. Biol Res Nurs. 2010;11(4):377–386. doi: 10.1177/1099800409344619. [DOI] [PubMed] [Google Scholar]
  • 6.Wharton KN, Pinar H, Stonestreet BS, et al. Severe umbilical cord inflammation—a predictor of periventricular leukomalacia in very low birth weight infants. Early Hum Dev. 2004;77(1-2):77–87. doi: 10.1016/j.earlhumdev.2004.02.001. [DOI] [PubMed] [Google Scholar]
  • 7.Malaeb S, Dammann O. Fetal inflammatory response and brain injury in the preterm newborn. J Child Neurol. 2009;24(9):1119–1126. doi: 10.1177/0883073809338066. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Shalak LF, Laptook AR, Jafri HS, et al. Clinical chorioamnionitis, elevated cytokines, and brain injury in term infants. Pediatrics. 2002;110(4):673–680. doi: 10.1542/peds.110.4.673. [DOI] [PubMed] [Google Scholar]
  • 9.Dammann O, O’Shea TM. Cytokines and perinatal brain damage. Clin Perinatol. 2008;35(4):643–663. doi: 10.1016/j.clp.2008.07.011. v. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Yoon BH, Jun JK, Romero R, et al. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1β, and tumor necrosis factor-α), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol. 1997;177(1):19–26. doi: 10.1016/s0002-9378(97)70432-0. [DOI] [PubMed] [Google Scholar]
  • 11.Yoon BH, Romero R, Kim CJ, et al. High expression of tumor necrosis factor-alpha and interleukin-6 in periventricular leukomalacia. Am J Obstet Gynecol. 1997;177(2):406–411. doi: 10.1016/s0002-9378(97)70206-0. [DOI] [PubMed] [Google Scholar]
  • 12.McAfoose J, Baune BT. Evidence for a cytokine model of cognitive function. Neurosci Biobehav Rev. 2009;33(3):355–366. doi: 10.1016/j.neubiorev.2008.10.005. [DOI] [PubMed] [Google Scholar]
  • 13.Deverman BE, Patterson PH. Cytokines and CNS development. Neuron. 2009;64(1):61–78. doi: 10.1016/j.neuron.2009.09.002. [DOI] [PubMed] [Google Scholar]
  • 14.Bilbo SD, Schwarz JM. Early-life programming of later-life brain and behavior: a critical role for the immune system. Front Behav Neurosci. 2009;3:14. doi: 10.3389/neuro.08.014.2009. (doi:10.3389/neuro.08.014.2009) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Boksa P. Effects of prenatal infection on brain development and behavior: a review of findings from animal models. Brain Behav Immun. 2010;24(6):881–897. doi: 10.1016/j.bbi.2010.03.005. [DOI] [PubMed] [Google Scholar]
  • 16.Hohlfeld R, Kerschensteiner M, Meinl E. Dual role of inflammation in CNS disease. Neurology. 2007;68(22 suppl 3):S58–S63. doi: 10.1212/01.wnl.0000275234.43506.9b. [DOI] [PubMed] [Google Scholar]
  • 17.Huleihel M, Golan H, Hallak M. Intrauterine infection/inflammation during pregnancy and offspring brain damages: possible mechanisms involved. Reprod Biol Endocrinol. 2004;2:17. doi: 10.1186/1477-7827-2-17. (doi:10.1186/1477-7827-2-17) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Quan N, Banks WA. Brain-immune communication pathways. Brain Behav Immun. 2007;21(6):727–735. doi: 10.1016/j.bbi.2007.05.005. [DOI] [PubMed] [Google Scholar]
  • 19.Wang X, Hellgren G, Löfqvist C, et al. White matter damage after chronic subclinical inflammation in newborn mice. J Child Neurol. 2009;24(9):1171–1178. doi: 10.1177/0883073809338068. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Wilson CJ, Finch CE, Cohen HJ. Cytokines and cognition—the case for a head-to-toe inflammatory paradigm. J Am Geriatr Soc. 2002;50(12):2041–2056. doi: 10.1046/j.1532-5415.2002.50619.x. [DOI] [PubMed] [Google Scholar]
  • 21.McAfoose J, Koerner H, Baune BT. The effects of TNF deficiency on age-related cognitive performance. Psychoneuroendocrinology. 2009;34(4):615–619. doi: 10.1016/j.psyneuen.2008.10.006. [DOI] [PubMed] [Google Scholar]
  • 22.Gutierrez EG, Banks WA, Kastin AJ. Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. J Neuroimmunol. 1993;47(2):169–176. doi: 10.1016/0165-5728(93)90027-v. [DOI] [PubMed] [Google Scholar]
  • 23.Yang GY, Gong C, Qin Z, et al. Tumor necrosis factor alpha expression produces increased blood-brain barrier permeability following temporary focal cerebral ischemia in mice. Brain Res Mol Brain Res. 1999;69(1):135–143. doi: 10.1016/s0169-328x(99)00007-8. [DOI] [PubMed] [Google Scholar]
  • 24.Ek M, Engblom D, Saha S, et al. Inflammatory response: pathway across the blood-brain barrier. Nature. 2001;410(6827):430–431. doi: 10.1038/35068632. [DOI] [PubMed] [Google Scholar]
  • 25.Saha RN, Liu X, Pahan K. Up-regulation of BDNF in astrocytes by TNF-α: a case for the neuroprotective role of cytokine. J Neuroimmune Pharmacol. 2006;1(3):212–222. doi: 10.1007/s11481-006-9020-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Bains JS, Oliet SH. Glia: they make your memories stick! Trends Neurosci. 2007;30(8):417–424. doi: 10.1016/j.tins.2007.06.007. [DOI] [PubMed] [Google Scholar]
  • 27.Baron R, Nemirovsky A, Harpaz I, et al. IFN-gamma enhances neurogenesis in wild-type mice and in a mouse model of Alzheimer’s disease. FASEB J. 2008;22(8):2843–2852. doi: 10.1096/fj.08-105866. [DOI] [PubMed] [Google Scholar]
  • 28.Lyon D, Cheng CY, Howland L, et al. Integrated review of cytokines in maternal, cord, and newborn blood: part I—associations with preterm birth. Biol Res Nurs. 2010;11(4):371–376. doi: 10.1177/1099800409344620. [DOI] [PubMed] [Google Scholar]
  • 29.Neta GI, von Ehrenstein OS, Goldman LR, et al. Umbilical cord serum cytokine levels and risks of small-for-gestational-age and preterm birth. Am J Epidemiol. 2010;171(8):859–867. doi: 10.1093/aje/kwq028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Orsi NM, Tribe RM. Cytokine networks and the regulation of uterine function in pregnancy and parturition. J Neuroendocrinol. 2008;20(4):462–469. doi: 10.1111/j.1365-2826.2008.01668.x. [DOI] [PubMed] [Google Scholar]
  • 31.Cliver SP, Goldenberg RL, Cutter GR, et al. The relationships among psychosocial profile, maternal size, and smoking in predicting fetal growth retardation. Obstet Gynecol. 1992;80(2):262–267. [PubMed] [Google Scholar]
  • 32.Goldenberg RL, DuBard MB, Cliver SP, et al. Pregnancy outcome and intelligence at age five years. Am J Obstet Gynecol. 1996;175(6):1511–1515. doi: 10.1016/s0002-9378(96)70099-6. [DOI] [PubMed] [Google Scholar]
  • 33.Bergsjø P, Hoffman HJ, Davis RO, et al. Preliminary results from the Collaborative Alabama and Scandinavian Study of Successive Small-for-Gestational Age Births. Acta Obstet Gynecol Scand. 1989;68(1):19–25. doi: 10.3109/00016348909087683. [DOI] [PubMed] [Google Scholar]
  • 34.Hadlock FP, Harrist RB, Martinez-Poyer J. In utero analysis of fetal growth: a sonographic weight standard. Radiology. 1991;181(1):129–133. doi: 10.1148/radiology.181.1.1887021. [DOI] [PubMed] [Google Scholar]
  • 35.Psychological Corporation. WPPSI-R: Wechsler Preschool and Primary Scale of Intelligence–Revised. San Antonio, TX: Harcourt Brace Jovanovich; 1989. [Google Scholar]
  • 36.American Association on Intellectual and Developmental Disabilities. Intellectual Disability: Definition, Classification, and Systems of Support. 11th ed. Annapolis Junction, MD: American Association on Intellectual and Developmental Disabilities; 2010. [DOI] [PubMed] [Google Scholar]
  • 37.Pearson Clinical Assessment. Peabody Picture Vocabulary Test–Revised. San Antonio, TX: Pearson Clinical Assessment; 1981. [Google Scholar]
  • 38.John F Kennedy Child Development Center. Home Screening Questionnaire. Denver, CO: Ladoca Publishing Foundation; 1981. [Google Scholar]
  • 39.Shrive FM, Stuart H, Quan H, et al. Dealing with missing data in a multi-question depression scale: a comparison of imputation methods. BMC Med Res Methodol. 2006;6:57. doi: 10.1186/1471-2288-6-57. (doi:10.1186/1471-2288-6-57) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Kenis G, Teunissen C, De Jongh R, et al. Stability of interleukin 6, soluble interleukin 6 receptor, interleukin 10 and CC16 in human serum. Cytokine. 2002;19(5):228–235. [PubMed] [Google Scholar]
  • 41.Porter AE, Auth J, Prince M, et al. Optimization of cytokine stability in stored amniotic fluid. Am J Obstet Gynecol. 2001;185(2):459–462. doi: 10.1067/mob.2001.115106. [DOI] [PubMed] [Google Scholar]
  • 42.Hornung RW, Reed LD. Estimation of average concentration in the presence of nondetectable values. Appl Occup Environ Hyg. 1990;5(9):46–51. [Google Scholar]
  • 43.US Census Bureau. Historical Poverty Tables. Current Population Survey. Washington, DC: Bureau of the Census, US Department of Commerce; 2010. ( http://www.census.gov/hhes/www/poverty/data/historical/index.html). (Accessed June 6, 2010) [Google Scholar]
  • 44.Doherty GH. Developmental switch in the effects of TNFα on ventral midbrain dopaminergic neurons. Neurosci Res. 2007;57(2):296–305. doi: 10.1016/j.neures.2006.10.019. [DOI] [PubMed] [Google Scholar]
  • 45.Oldreive CE, Doherty GH. Effects of tumour necrosis factor-alpha on developing cerebellar granule and Purkinje neurons in vitro. J Mol Neurosci. 2010;42(1):44–52. doi: 10.1007/s12031-010-9370-9. [DOI] [PubMed] [Google Scholar]
  • 46.Andrews WW, Cliver SP, Biasini F, et al. Early preterm birth: association between in utero exposure to acute inflammation and severe neurodevelopmental disability at 6 years of age. Am J Obstet Gynecol. 2008;198(4):466.e1–466.e11. doi: 10.1016/j.ajog.2007.12.031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Godbout JP, Johnson RW. Interleukin-6 in the aging brain. J Neuroimmunol. 2004;147(1-2):141–144. doi: 10.1016/j.jneuroim.2003.10.031. [DOI] [PubMed] [Google Scholar]
  • 48.Yaguchi M, Ohta S, Toyama Y, et al. Functional recovery after spinal cord injury in mice through activation of microglia and dendritic cells after IL-12 administration. J Neurosci Res. 2008;86(9):1972–1980. doi: 10.1002/jnr.21658. [DOI] [PubMed] [Google Scholar]
  • 49.Kim SJ, Son TG, Kim K, et al. Interferon-gamma promotes differentiation of neural progenitor cells via the JNK pathway. Neurochem Res. 2007;32(8):1399–1406. doi: 10.1007/s11064-007-9323-z. [DOI] [PubMed] [Google Scholar]
  • 50.Baune BT, Wiede F, Braun A, et al. Cognitive dysfunction in mice deficient for TNF- and its receptors. Am J Med Genet B Neuropsychiatr Genet. 2008;147B(7):1056–1064. doi: 10.1002/ajmg.b.30712. [DOI] [PubMed] [Google Scholar]
  • 51.Fontaine V, Mohand-Said S, Hanoteau N, et al. Neurodegenerative and neuroprotective effects of tumor necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2. J Neurosci. 2002;22(7):RC216. doi: 10.1523/JNEUROSCI.22-07-j0001.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Ashkenazi A, Dixit VM. Apoptosis control by death and decoy receptors. Curr Opin Cell Biol. 1999;11(2):255–260. doi: 10.1016/s0955-0674(99)80034-9. [DOI] [PubMed] [Google Scholar]
  • 53.Betjemann RS, Johnson EP, Barnard H, et al. Genetic covariation between brain volumes and IQ, reading performance, and processing speed. Behav Genet. 2010;40(2):135–145. doi: 10.1007/s10519-009-9328-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Edmonds CJ, Isaacs EB, Cole TJ, et al. The effect of intrauterine growth on verbal IQ scores in childhood: a study of monozygotic twins. Pediatrics. 2010;126(5):e1095–e1101. doi: 10.1542/peds.2008-3684. [DOI] [PubMed] [Google Scholar]
  • 55.Ek CJ, Dziegielewska KM, Stolp H, et al. Functional effectiveness of the blood-brain barrier to small water-soluble molecules in developing and adult opossum (Monodelphis domestica) J Comp Neurol. 2006;496(1):13–26. doi: 10.1002/cne.20885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Pollmächer T, Haack M, Schuld A, et al. Low levels of circulating inflammatory cytokines—do they affect human brain functions? Brain Behav Immun. 2002;16(5):525–532. doi: 10.1016/s0889-1591(02)00004-1. [DOI] [PubMed] [Google Scholar]
  • 57.Matoba N, Yu Y, Mestan K, et al. Differential patterns of 27 cord blood immune biomarkers across gestational age. Pediatrics. 2009;123(5):1320–1328. doi: 10.1542/peds.2008-1222. [DOI] [PubMed] [Google Scholar]
  • 58.Djuardi Y, Wibowo H, Supali T, et al. Determinants of the relationship between cytokine production in pregnant women and their infants. PLoS One. 2009;4(11):e7711. doi: 10.1371/journal.pone.0007711. (doi:10.1371/journal.pone.0007711) [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Web Tables

Articles from American Journal of Epidemiology are provided here courtesy of Oxford University Press

RESOURCES